Novo Nordisk Shares Jump After FDA Approves Pill Version of Wegovy
WSJ·2025-12-23 10:05Group 1 - The approval allows Novo Nordisk to recover market share lost to competitor Eli Lilly [1]
WSJ·2025-12-23 10:05 WSJ·2025-12-23 10:05 WSJ·2025-12-23 10:05Group 1 - The approval allows Novo Nordisk to recover market share lost to competitor Eli Lilly [1]